{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:13:47Z","timestamp":1792872827010,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.intimp.2022.109133","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T07:52:40Z","timestamp":1663055560000},"page":"109133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR\/P70S6K\/4EBP1 and NLRP3\/caspase-1\/IL-1\u03b2 pathways in MRL\/lpr mice"],"prefix":"10.1016","volume":"112","author":[{"given":"Xiaomei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-2977","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109133_b0005","article-title":"New insights into systemic lupus erythematosus therapies: 2010\u20132020[J]","author":"Wang","year":"2020","journal-title":"J. Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109133_b0010","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.semarthrit.2019.04.006","article-title":"Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus[J]","volume":"48","author":"Takeshima","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.intimp.2022.109133_b0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T Cell Metabolism: a new perspective on Th17\/Treg Cell Imbalance in systemic lupus erythematosus[J]","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2022.109133_b0020","unstructured":"<Glutamine-dependent \u03b1-ketoglutarate Production Regulates the Balance Between T Helper 1 Cell and Regulatory T Cell Generation.pdf>[J]."},{"issue":"5","key":"10.1016\/j.intimp.2022.109133_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108333","article-title":"Metabolic reprogramming induces germinal center B cell differentiation through Bcl6 locus remodeling[J]","volume":"33","author":"Haniuda","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.intimp.2022.109133_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2010.06.009","article-title":"Abnormalities of B cell subsets in patients with systemic lupus erythematosus[J]","volume":"363","author":"Dorner","year":"2011","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.intimp.2022.109133_b0035","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.10949","article-title":"Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus[J]","volume":"48","author":"Jacobi","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2022.109133_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mito.2018.01.002","article-title":"Alterations of oxygen consumption and extracellular acidification rates by glutamine in PBMCs of SLE patients[J]","volume":"44","author":"Lee","year":"2019","journal-title":"Mitochondrion"},{"issue":"11","key":"10.1016\/j.intimp.2022.109133_b0045","first-page":"1267","article-title":"Advances in therapeutic targets-related study on systemic lupus erythematosus[J]","volume":"46","author":"Wang","year":"2021","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"10.1016\/j.intimp.2022.109133_b0050","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1038\/s41467-018-06686-0","article-title":"Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells[J]","volume":"9","author":"Choi","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2022.109133_b0055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the international society of nephrology\/renal pathology society classification for lupus nephritis: clarification of definitions, and modified national institutes of health activity and chronicity indices[J]","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2022.109133_b0060","article-title":"Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target[J]","volume":"102861","author":"Lou","year":"2022","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.intimp.2022.109133_b0065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1165\/rcmb.2017-0238OC","article-title":"Glutaminolysis Promotes Collagen Translation and Stability via alpha-Ketoglutarate-mediated mTOR Activation and Proline Hydroxylation[J]","volume":"58","author":"Ge","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"22","key":"10.1016\/j.intimp.2022.109133_b0070","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.4161\/cc.22632","article-title":"Glutaminolysis feeds mTORC1[J]","volume":"11","author":"Duran","year":"2012","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.intimp.2022.109133_b0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases[J]","volume":"12","author":"Perl","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109133_b0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrrheum.2015.178","article-title":"Systemic lupus erythematosus in 2015: Cellular and metabolic requirements of effector T cells[J]","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109133_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084208","article-title":"The Role of Inflammasomes in Glomerulonephritis[J]","volume":"23","author":"Anton-Pampols","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109133_b0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12847","article-title":"Metabolic determinants of lupus pathogenesis[J]","volume":"295","author":"Teng","year":"2020","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2022.109133_b0095","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.biocel.2009.03.003","article-title":"Glutamine homeostasis and mitochondrial dynamics[J]","volume":"41","author":"Mates","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109133_b0100","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1172\/JCI129269","article-title":"GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis[J]","volume":"130","author":"Xia","year":"2020","journal-title":"J. Clin. Investigation"},{"issue":"4","key":"10.1016\/j.intimp.2022.109133_b0105","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer[J]","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.intimp.2022.109133_b0110","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","article-title":"Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice[J]","volume":"182","author":"Blair","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109133_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive Mechanisms of Regulatory B Cells[J]","volume":"12","author":"Catalan","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109133_b0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4161\/gmic.1.2.11515","article-title":"Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora[J]","volume":"1","author":"Ochoa-Reparaz","year":"2010","journal-title":"Gut. Microbes"},{"issue":"9","key":"10.1016\/j.intimp.2022.109133_b0125","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/mt.2012.127","article-title":"Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization[J]","volume":"20","author":"Hsieh","year":"2012","journal-title":"Mol. Ther."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2022.109133_b0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molimm.2013.02.003","article-title":"Recombinant murine calreticulin fragment 39\u2013272 expands CD1d(hi)CD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL\/6 mice[J]","volume":"55","author":"Hong","year":"2013","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109133_b0135","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis[J]","volume":"178","author":"Evans","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109133_b0140","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity[J]","volume":"184","author":"Watanabe","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109133_b0145","article-title":"An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus[J]","author":"Sumikawa","year":"2021","journal-title":"Rheumatol. (Oxford)"},{"issue":"2","key":"10.1016\/j.intimp.2022.109133_b0150","doi-asserted-by":"crossref","first-page":"e13139","DOI":"10.1111\/sji.13139","article-title":"B cell class switching in intestinal immunity in health and disease[J]","volume":"95","author":"Fleming","year":"2022","journal-title":"Scand J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109133_b0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2011.08.005","article-title":"Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus[J]","volume":"141","author":"Dolff","year":"2011","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109133_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/eji.201545760","article-title":"T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis[J]","volume":"46","author":"Blanco","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109133_b0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus[J]","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109133_b0170","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.09.022","article-title":"Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway[J]","volume":"50","author":"He","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.intimp.2022.109133_b0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer[J]","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"38","key":"10.1016\/j.intimp.2022.109133_b0180","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/onc.2012.465","article-title":"HIF-independent role of prolyl hydroxylases in the cellular response to amino acids[J]","volume":"32","author":"Duran","year":"2013","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.intimp.2022.109133_b0185","doi-asserted-by":"crossref","first-page":"e0185092","DOI":"10.1371\/journal.pone.0185092","article-title":"Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition[J]","volume":"12","author":"Lampa","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2022.109133_b0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000088","article-title":"The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?[J]","volume":"26","author":"Kahlenberg","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.intimp.2022.109133_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107375","article-title":"Curcumin analogue AI-44 alleviates MSU-induced gouty arthritis in mice via inhibiting cathepsin B-mediated NLRP3 inflammasome activation[J]","volume":"93","author":"Gu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109133_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105682","article-title":"Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice[J]","volume":"74","author":"Deng","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109133_b0205","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/art.38993","article-title":"Lupus nephritis: glycogen synthase kinase 3beta promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice[J]","volume":"67","author":"Zhao","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109133_b0210","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10753-021-01439-6","article-title":"The Signaling Pathways Regulating NLRP3 Inflammasome Activation[J]","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.intimp.2022.109133_b0215","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/abbs\/gmy088","article-title":"mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus[J]","volume":"50","author":"Li","year":"2018","journal-title":"Acta. Biochim. Biophys. Sin. (Shanghai)"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2025.115796","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000}},{"DOI":"10.1016\/j.intimp.2025.115796","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:38:05Z","timestamp":1771724285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922006178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":43,"alternative-id":["S1567576922006178"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109133","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR\/P70S6K\/4EBP1 and NLRP3\/caspase-1\/IL-1\u03b2 pathways in MRL\/lpr mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109133"}}